Frontier Royalty Agreement & Notice of Interims

RNS Number : 4923F
Science Group PLC
19 July 2021
 

 

 

 

 

19 July 2021

 

Frontier Royalty Agreement and Notice of Interim Results

 

Frontier Smart Technologies was acquired by Science Group plc in 2019. The original technology used by Frontier was developed by Imagination Technologies Limited ("Imagination") and Frontier has paid licence royalties to Imagination on a quarterly basis. For the year ended 31 December 2020, such royalty payments totalled $1.0 million.

 

As part of the Frontier strategy review, agreement has now been reached with Imagination to settle all future royalties associated with the use of the licensed technology in consumer electronics (including DAB radio broadcast) for a single payment of $6.0 million.

 

This agreement is effective 1 July 2021 and is anticipated to be earnings enhancing in the second half of the current year and beyond.

 

 

Interim Results

 

The results for the 6 month period ending 30 June 2021 are anticipated to be released on Monday 26 July 2021.

 

 

 

End

 

Science Group plc     Tel : +44 (0) 1223 875200

  Martyn Ratcliffe, Chairman 

 

Stifel Nicolaus Europe Limited (Nominated Adviser & Broker)  Tel : +44 (0) 20 7710 7600

Nick Adams, Alex Price

 

Liberum Capital Limited (Joint Broker)  Tel: +44 (0) 20 3100 2000

Neil Patel, Cameron Duncan

 

This announcement contains inside information. The person responsible for this announcement is Martyn Ratcliffe.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRFIFSADAIRLIL
UK 100

Latest directors dealings